Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.28 Billion JPY | 7.47% |
| 2022 | 13.04 Billion JPY | 34.68% |
| 2021 | 9.68 Billion JPY | 28.23% |
| 2020 | 7.55 Billion JPY | -0.81% |
| 2019 | 7.61 Billion JPY | 23.28% |
| 2018 | 6.17 Billion JPY | 18.71% |
| 2017 | 5.2 Billion JPY | 19.35% |
| 2016 | 4.36 Billion JPY | 62.03% |
| 2015 | 2.69 Billion JPY | -54.79% |
| 2014 | 5.95 Billion JPY | 3.55% |
| 2013 | 5.74 Billion JPY | 22.65% |
| 2012 | 4.68 Billion JPY | 42.2% |
| 2011 | 3.29 Billion JPY | -36.89% |
| 2010 | 5.22 Billion JPY | -16.1% |
| 2009 | 6.22 Billion JPY | -8.95% |
| 2008 | 6.83 Billion JPY | -11.08% |
| 2007 | 7.68 Billion JPY | 14.77% |
| 2006 | 6.69 Billion JPY | 24.33% |
| 2005 | 5.38 Billion JPY | 33.55% |
| 2004 | 4.03 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.02 Billion JPY | -36.26% |
| 2023 Q1 | 3.19 Billion JPY | -27.41% |
| 2023 Q2 | 3.15 Billion JPY | -1.08% |
| 2023 Q3 | 3.18 Billion JPY | 0.77% |
| 2023 Q4 | 4.74 Billion JPY | 49.04% |
| 2023 FY | 14.02 Billion JPY | 7.47% |
| 2022 Q1 | 2.05 Billion JPY | -22.92% |
| 2022 Q3 | 3.24 Billion JPY | -3.25% |
| 2022 Q4 | 4.39 Billion JPY | 35.74% |
| 2022 FY | 13.04 Billion JPY | 34.68% |
| 2022 Q2 | 3.35 Billion JPY | 63.04% |
| 2021 Q2 | 2.75 Billion JPY | 76.46% |
| 2021 FY | 9.68 Billion JPY | 28.23% |
| 2021 Q1 | 1.56 Billion JPY | -38.2% |
| 2021 Q3 | 2.7 Billion JPY | -2.05% |
| 2021 Q4 | 2.66 Billion JPY | -1.3% |
| 2020 Q1 | 1.58 Billion JPY | -33.28% |
| 2020 FY | 7.55 Billion JPY | -0.81% |
| 2020 Q4 | 2.52 Billion JPY | 58.31% |
| 2020 Q2 | 1.84 Billion JPY | 16.5% |
| 2020 Q3 | 1.59 Billion JPY | -13.42% |
| 2019 Q1 | 1.48 Billion JPY | -7.99% |
| 2019 Q2 | 2 Billion JPY | 35.35% |
| 2019 Q3 | 1.74 Billion JPY | -13.02% |
| 2019 FY | 7.61 Billion JPY | 23.28% |
| 2019 Q4 | 2.37 Billion JPY | 35.77% |
| 2018 Q2 | 1.68 Billion JPY | 32.08% |
| 2018 Q3 | 1.59 Billion JPY | -5.49% |
| 2018 Q4 | 1.61 Billion JPY | 1.08% |
| 2018 FY | 6.17 Billion JPY | 18.71% |
| 2018 Q1 | 1.27 Billion JPY | -36.79% |
| 2017 Q4 | 2.02 Billion JPY | 109.22% |
| 2017 Q3 | 966.94 Million JPY | -29.33% |
| 2017 Q2 | 1.36 Billion JPY | 61.76% |
| 2017 FY | 5.2 Billion JPY | 19.35% |
| 2017 Q1 | 845.85 Million JPY | -54.79% |
| 2016 FY | 4.36 Billion JPY | 62.03% |
| 2016 Q2 | 755.54 Million JPY | 16.62% |
| 2016 Q3 | 1.08 Billion JPY | 43.7% |
| 2016 Q4 | 1.87 Billion JPY | 72.34% |
| 2016 Q1 | 647.85 Million JPY | -37.62% |
| 2015 Q3 | 708.28 Million JPY | 18.92% |
| 2015 Q2 | 595.6 Million JPY | 70.87% |
| 2015 Q1 | 348.56 Million JPY | -81.87% |
| 2015 FY | 2.69 Billion JPY | -54.79% |
| 2015 Q4 | 1.03 Billion JPY | 46.62% |
| 2014 Q4 | 1.92 Billion JPY | 24.61% |
| 2014 FY | 5.95 Billion JPY | 3.55% |
| 2014 Q3 | 1.54 Billion JPY | 23.97% |
| 2014 Q2 | 1.24 Billion JPY | 0.2% |
| 2014 Q1 | 1.24 Billion JPY | -44.98% |
| 2013 Q2 | 1.19 Billion JPY | 14.78% |
| 2013 Q1 | 1.04 Billion JPY | -10.05% |
| 2013 Q3 | 1.25 Billion JPY | 4.88% |
| 2013 FY | 5.74 Billion JPY | 22.65% |
| 2013 Q4 | 2.25 Billion JPY | 80.05% |
| 2012 Q2 | 1.13 Billion JPY | -7.82% |
| 2012 Q3 | 1.16 Billion JPY | 3.09% |
| 2012 FY | 4.68 Billion JPY | 42.2% |
| 2012 Q1 | 1.22 Billion JPY | 1014.93% |
| 2012 Q4 | 1.15 Billion JPY | -0.83% |
| 2011 FY | 3.29 Billion JPY | -36.89% |
| 2011 Q4 | 110.2 Million JPY | -90.54% |
| 2011 Q3 | 1.16 Billion JPY | 31.18% |
| 2011 Q2 | 888.3 Million JPY | -21.53% |
| 2011 Q1 | 1.13 Billion JPY | -20.19% |
| 2010 Q4 | 1.41 Billion JPY | -1.2% |
| 2010 Q3 | 1.43 Billion JPY | 11.75% |
| 2010 Q1 | 1.08 Billion JPY | -23.21% |
| 2010 FY | 5.22 Billion JPY | -16.1% |
| 2010 Q2 | 1.28 Billion JPY | 18.52% |
| 2009 Q3 | 1.29 Billion JPY | -23.96% |
| 2009 Q4 | 1.41 Billion JPY | 9.05% |
| 2009 FY | 6.22 Billion JPY | -8.95% |
| 2009 Q1 | 1.81 Billion JPY | -4.02% |
| 2009 Q2 | 1.7 Billion JPY | -6.3% |
| 2008 Q3 | 1.3 Billion JPY | -14.59% |
| 2008 FY | 6.83 Billion JPY | -11.08% |
| 2008 Q4 | 1.89 Billion JPY | 44.62% |
| 2008 Q2 | 1.53 Billion JPY | 0.0% |
| 2007 FY | 7.68 Billion JPY | 14.77% |
| 2006 FY | 6.69 Billion JPY | 24.33% |
| 2005 FY | 5.38 Billion JPY | 33.55% |
| 2004 FY | 4.03 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DNA Chip Research Inc. | 66.35 Million JPY | -21425.141% |
| Cosmo Bio Company,Limited | 3.25 Billion JPY | -339.464% |
| H.U. Group Holdings, Inc. | 63.23 Billion JPY | 77.413% |
| FALCO HOLDINGS Co., Ltd. | 12.71 Billion JPY | -12.32% |
| BML, Inc. | 45.62 Billion JPY | 68.698% |
| Human Metabolome Technologies, Inc. | 869.33 Million JPY | -1542.937% |
| Precision System Science Co., Ltd. | 950.37 Million JPY | -1402.833% |